Published by Josh White on 23rd June 2025
(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational treatment for cholestatic pruritus in patients with primary biliary cholangitis (PBC).
URL: http://www.digitallook.com/dl/news/story/35167546/...